United States
US 12,702,667 B2
Focal adhesion kinase inhibitor as a therapeutic agent in diabetes
US 12,702,667 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-11. Applicant: University of Pittsburgh - Of the Commonwealth System of Higher Education. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- University of Pittsburgh - Of the Commonwealth System of Higher Education
- Inventors
- Farzad Esni; Jing Hu
- Publication date
- 2026-08-11
- Filing date
- 2019-08-13
- Document type
- B2 Granted patent
- Also written as
- US 12,702,667 B2 · US12702667 · 12702667
Abstract
It is disclosed herein that a FAK inhibitor induces conversion of acinar cells into beta cells. Methods are provided for increasing beta cell proliferation by administering an effective amount of a FAK inhibitor to a subject in need thereof. Methods are also provided for treating a subject with diabetes or at risk of developing diabetes, comprising administering to the subject a therapeutically effective amount of a FAK inhibitor.
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free